Pfizer is buying a cancer biotech in one of the biggest pharma deals in historyByAnnalisa MerelliPublishedMarch 13, 2023
China’s covid cases loom over upcoming WHO meeting on state of the pandemicByDiego Lasarte and Sofia Lotto PersioPublishedJanuary 26, 2023
WHO approves generic Paxlovid drug for covid treatment in low-income countriesByAnnalisa MerelliPublishedJanuary 3, 2023
🔮 What lies ahead in 2023ByJulia Malleck, Sofia Lotto Persio, and Morgan HaefnerPublishedJanuary 1, 2023
BioNTech is set to ship its first modular mRNA vaccine factory to RwandaByAnnalisa MerelliPublishedDecember 29, 2022
Africa's official covid vaccination rates are about to go up by a lotByAnnalisa MerelliPublishedDecember 28, 2022
The US may make anti-overdose drug naloxone available over the counter in 2024ByAnnalisa MerelliPublishedDecember 27, 2022
How AbbVie denied Americans access to fair competition for HumiraByAnnalisa MerelliPublishedDecember 14, 2022
